Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in developing therapeutic strategies for Alzheimer's disease
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111623-111623
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Applications of Carbon Dots for the Treatment of Alzheimer’s Disease
Feng Guo, Qingman Li, Xiaolin Zhang, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6621-6638
Open Access | Times Cited: 16
Cell membrane-based nanomaterials for theranostics of central nervous system diseases
Wenyue Li, Junwei Cheng, Fangfei He, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
A Greedy Optimized Intelligent Framework for Early Detection of Alzheimer’s Disease Using EEG Signal
R. Swarnalatha
Computational Intelligence and Neuroscience (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 9
Memantine versus Ginkgo biloba Extract: A Comparative Study on Cognitive Dysfunction Treatment in a Novel Rat Model
Essmat A. H. Allam, Abdel-Azim Assi, Dalia M. Badary, et al.
Planta Medica (2024) Vol. 90, Iss. 04, pp. 286-297
Closed Access | Times Cited: 3
Crocin nano-chitosan-coated compound improves anxiety disorders, learning, and spatial memory in Alzheimer's model induced by beta-amyloid in rats.
Gholam Hossein Meftahi, Mohsen Khodadadi, Gila Pirzad Jahromi, et al.
PubMed (2024) Vol. 27, Iss. 7, pp. 879-887
Closed Access | Times Cited: 3
Alzheimer’s Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions
Anuvab Dey, Subhrojyoti Ghosh, Ramya Lakshmi Rajendran, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9690-9690
Open Access | Times Cited: 3
Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
Zaida L. Almeida, Daniela C. Vaz, Rui M. M. Brito
Molecular Neurobiology (2024)
Open Access | Times Cited: 3
Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders
Thuy Trang Nguyen, Phuong‐Trang Nguyen‐Thi, Thi Hong Anh Nguyen, et al.
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 4, pp. 457-473
Closed Access | Times Cited: 8
ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation
Pooja Khairnar, Ajit Singh, Kailash Ahirwar, et al.
AAPS PharmSciTech (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 8
Recent advances in brain delivery of synthetic and natural nano therapeutics: Reviving hope for Alzheimer's disease patients
Doaa Sayed Nady, Udo Bakowsky, Sherif Ashraf Fahmy
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105047-105047
Open Access | Times Cited: 7
Analysis of ROQUIN, Tristetraprolin (TTP), and BDNF/miR-16/TTP regulatory axis in late onset Alzheimer’s disease
Mohammad Reza Asadi, Mahnaz Talebi, Jalal Gharesouran, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 10
Digital Intervention for the Management of Alzheimer’s Disease
Namish Manchanda, Akanksha Aggarwal, Sonal Setya, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 14, pp. 909-932
Closed Access | Times Cited: 9
Paving the Way for Reliable Alzheimer's Disease Blood Diagnosis by Quadruple Electrochemical Immunosensing
Alejandro Valverde, José M. Gordón Pidal, Ana Montero‐Calle, et al.
ChemElectroChem (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 8
Epidermal Growth Factor Receptor Kinase Inhibitor Ameliorates β-Amyloid Oligomer-Induced Alzheimer Disease in Swiss Albino Mice
Jagadeesh Dhamodharan, Ganthimathy Sekhar, Arunachalam Muthuraman
Molecules (2022) Vol. 27, Iss. 16, pp. 5182-5182
Open Access | Times Cited: 8
Korean Red Pine (Pinus densiflora) Bark Extract Attenuates Aβ-Induced Cognitive Impairment by Regulating Cholinergic Dysfunction and Neuroinflammation
Min Ji Go, Jong Min Kim, Jin Yong Kang, et al.
Journal of Microbiology and Biotechnology (2022) Vol. 32, Iss. 9, pp. 1154-1167
Open Access | Times Cited: 8
Intranasal Administration as a Route to Deliver Drugs to the Brain (Review)
Natalia N. Porfiryeva, И. И. Семина, Rouslan I. Moustafine, et al.
Drug development & registration (2021) Vol. 10, Iss. 4, pp. 117-127
Open Access | Times Cited: 11
Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer’s Disease
Felix Oluwasegun Ishabiyi, James Okwudirichukwu Ogidi, Baliqis Adejoke Olukade, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. s1, pp. S67-S85
Open Access | Times Cited: 4
Exploring the effectiveness and safety profile of TAU protein antibodies as potential therapies for alzheimer's disease: a comprehensive review
Muhammad Essa, N. Zaheer Ahmed, Amanullah Kakar, et al.
(2024)
Open Access | Times Cited: 1
Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer’s Disease Treatment
Gabriela Dumitrița Stanciu, Daniela Carmen Ababei, Carmen Solcan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 530-530
Open Access | Times Cited: 1
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications
Md. Ataur Rahman, MD. Hasanur Rahman, Hyewhon Rhim, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 12, pp. 1942-1959
Closed Access | Times Cited: 1
The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review)
G. A. Fursa, S. S. Andretsova, V. S. Shishkina, et al.
Bulletin of Experimental Biology and Medicine (2024)
Closed Access | Times Cited: 1
Applications and Developments of Gene Therapy Drug Delivery Systems for Neurological Disorders
Ngoc Hong Nguyen, Phuong‐Trang Nguyen‐Thi, Thuy Trang Nguyen, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 12
Closed Access | Times Cited: 1
Green synthesis of nanoparticles using medicinal plants as an eco-friendly and therapeutic potential approach for neurodegenerative diseases: a comprehensive review
Rezvan Izadi, Seifollah Bahramikia, Vali Akbari
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Pharmacological implications of ipriflavone against environmental metal–induced neurodegeneration and dementia in rats
Hend M. Hussien, Doaa A. Ghareeb, Hany E. A. Ahmed, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 46, pp. 65349-65362
Closed Access | Times Cited: 10
Z-scan optical method complements the Thioflavin T assay for investigation of anti-Alzheimer's impact of polyphenols
Mohammad Jamali, Salman Mohajer, Sara Sheikhlary, et al.
Photodiagnosis and Photodynamic Therapy (2022) Vol. 39, pp. 102914-102914
Closed Access | Times Cited: 6

Scroll to top